Page last updated: 2024-08-24

tirofiban and Angiogenesis, Pathologic

tirofiban has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertrand, M; Demopoulos, LA; DiBattiste, PM; Grines, CL; Harris, KE; Herrmann, HC; Meier, B; Moliterno, DJ; Powers, ER; Roffi, M; Topol, EJ1

Trials

1 trial(s) available for tirofiban and Angiogenesis, Pathologic

ArticleYear
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up.
    Circulation, 2002, Jun-11, Volume: 105, Issue:23

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Circulation; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Insulin; Integrins; Kinetics; Male; Middle Aged; Neovascularization, Pathologic; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine

2002
chemdatabank.com